000 01451 a2200457 4500
005 20250513075411.0
264 0 _c19931028
008 199310s 0 0 eng d
022 _a0016-5085
024 7 _a10.1016/0016-5085(93)90965-f
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPisegna, J R
245 0 0 _aAn evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma.
_h[electronic resource]
260 _bGastroenterology
_cOct 1993
300 _a1179-83 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGastrinoma
_xepidemiology
650 0 4 _aGastrins
_xblood
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xadverse effects
650 0 4 _aLiver Neoplasms
_xepidemiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRecombinant Proteins
_xadverse effects
650 0 4 _aZollinger-Ellison Syndrome
_xpathology
700 1 _aSlimak, G G
700 1 _aDoppman, J L
700 1 _aStrader, D B
700 1 _aMetz, D C
700 1 _aBenya, R V
700 1 _aOrbuch, M
700 1 _aFishbeyn, V A
700 1 _aFraker, D L
700 1 _aNorton, J A
773 0 _tGastroenterology
_gvol. 105
_gno. 4
_gp. 1179-83
856 4 0 _uhttps://doi.org/10.1016/0016-5085(93)90965-f
_zAvailable from publisher's website
999 _c8405137
_d8405137